Cargando…
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
The development and implementation of Immune Checkpoint Inhibitors (ICI) in clinical oncology have significantly improved the survival of a subset of cancer patients with metastatic disease previously considered uniformly lethal. However, the low response rates and the low number of patients with du...
Autores principales: | Engelsen, Agnete S. T., Lotsberg, Maria L., Abou Khouzam, Raefa, Thiery, Jean-Paul, Lorens, James B., Chouaib, Salem, Terry, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092944/ https://www.ncbi.nlm.nih.gov/pubmed/35572601 http://dx.doi.org/10.3389/fimmu.2022.869676 |
Ejemplares similares
-
Decoding cancer’s camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade
por: Lotsberg, Maria L., et al.
Publicado: (2020) -
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
por: Abou Khouzam, Raefa, et al.
Publicado: (2021) -
The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
por: Abou Khouzam, Raefa, et al.
Publicado: (2022) -
An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
por: Abou Khouzam, Raefa, et al.
Publicado: (2021) -
New insights into the role of EMT in tumor immune escape
por: Terry, Stéphane, et al.
Publicado: (2017)